FROST Clinical Study
Freezing Alone Instead of Resection of Small Breast Tumors: A Study of Cryoablation in the Management of Early Stage Breast Cancer (FROST).
Sanarus Technologies is sponsoring a multi-center clinical study to treat breast cancer in those who prefer an alternative to surgery.
Participants must have the following:
- Age: 50 and older
- A cancer that is ≤1.5cm in its greatest diameter
- A cancer that has not spread to other organs
- A cancer that is strongly sensitive to estrogen
- No prior treatment of the current breast cancer
If you would like more information, please contact us.
You can also find additional information about FROST Clinical Study on clinicaltrials.gov